- OMXSPI 0.97% 795.37
- FN25 1.29% 2239.33
- OMXS30 0.83% 2155.49
Emotra
Mangold OTC
0.05
0.03 150 %
Stock information
- Company Emotra
- Currency SEK
- Turnover -
- % 150
- + / - 0.03
- Buy -
- Sell -
- High -
- Low -
- Last updated 2022-10-20 08:16
Company information
Emotra develops products intended to increase patient safety in healthcare and welfare. The products are specifically designed as quantitative and objective measuring instruments, with the vision of facilitating for and supporting the caregiver in the assessment of the potential suicidal tendencies of the patient. Customers are made up of specialist clinics, universities and research institutes across the Nordic market.
- Number of shares 373 Millions
- Stock market value 19 MSEK
- Average daily turnover 40 TSEK
- CEO Daniel Rudeklint
- Chairman of the Board Claes Holmberg
- Volatility 30 days 405.47%
- Volatility 200 days 320.27%
- Dividend -
- Latest annual report -
- Absolute return -
Owners
| Name | Ownership | Last modified |
|---|---|---|
| ScanInvest Ltd | 19.93% | 2022-01-17 |
| Jan Samzelius | 9.39% | 2022-01-18 |
| Christina Karlström | 7.67% | 2022-01-18 |
| Maida Vale Capital AB | 5.76% | 2022-01-18 |
| Wisialowski Living Trust | 4.91% | 2022-01-17 |
| Avanza Pension | 1.45% | 2022-01-21 |
| Ero Naderi | 0.81% | 2022-01-21 |
| Erik Nerep | 0.67% | 2022-01-21 |
| Joakim Bjärkeback | 0.58% | 2022-01-21 |
| Anders Friberg | 0.36% | 2022-01-21 |